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We need public health systems that can quickly 
diagnose outbreaks, whatever their source, 
and mobilize the right medical resources and 
personnel. By making any one country more 
secure, we make the international community
more secure at the same time.
— Secretary of State, Hillary Rodham Clinton, December 7th, 2011. 
Remarks at the 7th Biological and Toxin Weapons Review Conference
AUGUST 2012
To stop disease that spreads across borders, 
we must strengthen our systems of public health.
We will focus on the health of mothers and 
children. And we must come together to prevent, 
detect, and fight every kind of biological 
danger— whether it is a pandemic like H1N1, 
a terrorist threat, or a treatable disease...
— President Barack Obama, September 21st, 2011. 
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Global disease detection and emergency response has always been a core public health activity for 
CDC, ensuring the public health security of Americans and others around the world. Over the past 
year, the agency continued to formalize this by centralizing activities in the Division of Global Disease 
Detection and Emergency Response (DGDDER) that now span all facets of global health security.
Our founding Global Disease Detection Program (GDD), was established in 2004 to promote global 
health security by building capacity to rapidly detect and contain emerging health threats. In the last 
eight years, the GDD Program has grown by establishing seven GDD Regional Centers and three GDD 
Regional Centers under development. With the formation of CDC’s Center for Global Health in 2010, 
DGDDER was established not just to include GDD but also International Emergency and Refugee 
Health, Global Health Security, and Health Systems Reconstruction programs. This structure has led 
to increased collaborations among the programs as well as an increased network of partnerships 
throughout CDC.
In 2011, CDC coordinated and contributed to several high-profile and important responses including 
cholera in Haiti, famine in the Horn of Africa, and outbreaks of typhoid, Ebola, and dengue fever. In 
addition, CDC programs worked together to build host country capacity for global health security 
and the International Health Regulations (IHR), including developing surveillance and epidemiologic 
systems, strengthening laboratories, and increasing public health workforce overseas. The GDD 
Regional Centers have also continued to provide key field support and leadership for global disease 
threat and response, as highlighted by the 2011 monitoring and evaluation data in this report.
These events and outbreaks of 2011 reminded us that emerging health threats and humanitarian 
emergencies remain a complicated reality, yet they also highlight the value of our robust network 
of partners, which is essential for building capacity and rapidly responding to events. As the World 
Health Organization (WHO) Collaborating Center for Implementation of IHR National Surveillance 
and Response Capacity, and through ongoing work with our host country partners, we are making 
important progress towards building health security globally. In coordination with WHO, U.S. Agency 
for International Development, U.S. Department of State, U.S. Department of Defense, and others,
CDC is strategically placing scientific expertise and resources in each of the WHO regions to build 
and strengthen national public health core capacities in host countries and throughout the region. 
Increased collaboration between CDC programs and global partner networks has meant that our 
efforts in 2011 were stronger and more meaningful than ever.
Thank you for your continued interest in CDC’s work on global disease detectionand emergency 
response. We hope you will enjoy reading and learning about the most recent accomplishments. We 
look forward to the coming year as CDC continues to work with global partners to ensure health 
security for our citizens by strengthening the global capacity to control emerging health threats.
Scott F. Dowell, MD, MPH 
Director, Division of Global Disease Detection and Emergency Response
Center for Global Health 
Centers for Disease Control and Prevention
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Introduction
In recent years, the statement that diseases know no borders has become a truism, 
validated by infectious disease threats such as SARS, avian influenza, and drug-resistant 
tuberculosis. These diseases repeatedly cross national borders and pose immediate 
threats to the United States. Humanitarian emergencies, including the earthquake in Haiti, 
flooding in Pakistan, and famine in the Horn of Africa, are not isolated incidents but 
global crises which can sometimes have immediate and long-term effects throughout the 
world. It is also increasingly recognized that a one-time response is often not adequate 
and investments must be made in public health reconstruction in order to be better 
prepared for future emergencies. As emphasized in the Biological Weapons Convention 
Review Conference of 2011, the human and financial devastation of infectious diseases 
are still an ever-present danger to the world. In short: investments in global health 
security matter now more than ever.
The World Health Organization (WHO) defines global health security as the reduction 
in vulnerability of people around the world to new, acute or rapidly spreading risks to 
health, particularly those that threaten to cross international borders. President Obama’s 
National Strategy for Countering Biological Threats (2009) similarly defines global health 
security as the reduction in threats from outbreaks of infectious disease whether natural, 
accidental or deliberate in nature.
While the U.S. has made substantial progress with partner nations to implement disease 
surveillance programs and respond at the source, the threats posed by emerging 
pandemics remain a challenge to global security, threatening economies and increasing 
political instability. CDC’s global disease detection and emergency response activities 
help protect the global community from urgent public health threats and mitigate 
humanitarian emergencies. CDC health experts overseas collaborate with ministries of 
health (MOH) to not only keep their people safe, but also protect Americans against the 
spread of disease to the U.S.
CDC’s global disease detection and emergency response activities have enhanced global 
health security since 2004 with current tasks focusing on:
■ Detecting and containing emerging health threats
■ Deploying CDC experts 24 hours a day, 7 days a week at country request
■ Building capacity in support of the International Health Regulations (IHR)
■ Promoting policies for public health and health security
■ Responding to complex humanitarian emergencies
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CDC’s Division of Global Disease Detection and Emergency Response collaborates with 
centers and programs across CDC to accomplish its mission. This collaboration allows 
CDC to draw upon expertise from across the agency. The Division also works closely 
with a variety of in-country partners including MOHs, academic institutions, U.S. Agency 
for International Development (USAID), U.S. Department of State (DOS), U.S. Department 
of Defense (DOD), and international and non-government organizations. These partners 
contribute funding, expertise, and other resources towards CDC projects and goals. 
Therefore, the results of our work are shared accomplishments of CDC and its partners.
We view global health security as a continuum that covers the pre-emergency phase all 
the way through to recovery and can be divided into four sections: building capacity, 
monitoring and detecting threats, responding to international emergencies, and 
reconstructing health systems. The work of the Division of Global Disease Detection and 
Emergency Response covers all four components of the global health security emergency 
continuum. This also means that our branches and offices work closely together to 
coordinate efforts and ensure a seamless transition during emergencies.
Partnerships
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Contributions to the International Health Regulations
As the WHO collaborating center for implementation of the International Health 
Regulations (IHR) National Surveillance and Response Capacity, CDC’s Division of Global 
Disease Detection and Emergency Response contributes to IHR capacity building as 
part of our mandate. With 194 member countries, the revised IHR is a legally binding 
international agreement which provides the world with a means for harmonizing action 
among member states and a framework for identifying, reporting, and responding to 
public health emergencies of international concern (PHEIC), regardless of their origin or 
source. The IHR requires member states to fulfill numerous obligations, which require 
political, financial, and technical commitment to prevent and control the spread of 
disease inside and outside of their borders.
We have made support and assistance for IHR implementation in partner countries a key 
driving force for our work, particularly our collaborations with host nations, other U.S. 
government agencies, and other partners. CDC’s efforts are focused on (but not limited
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to) to the four United States Government goals for IHR implementation: surveillance, 
response, human resources, and laboratory. CDC collaborates with U.S. embassies and 
U.S. Government partners in host countries to leverage current investments and efforts. 
For example, the GDD Regional Centers help develop key surveillance systems and 
train its workforce through various training programs. The GDD Operations Center 
conducts event-based surveillance and deployments to improve detection and response. 
The International Emergency and Refugee Health Branch is building surveillance and 
preparedness systems in host countries focusing on humanitarian activities and refugees, 
and the Heath Systems Reconstruction Office is working to develop multiple surveillance 
and laboratory systems in Haiti. Finally, the Global Health Security Branch provides 
leadership in the development and implementation of high-level U.S. Government IHR 
planning frameworks and country toolkits. These are just a few examples of CDC’s 
contributions, but with collaboration and support from our partners, CDC will continue 
to build IHR capacities worldwide.
Where we work
Countries with permanent 
staff assigned to GDD 
Regional Centers
(Multiple division staff 
assigned to host-country: 
multiple/extensive projects)
Countries where direct 


















Many countries lack the capacity and appropriate health infrastructure to effectively monitor, 
report, and respond to disease threats. CDC's activities reduce this risk by providing technical 
assistance to host countries to build on-the-ground capacity to detect deadly outbreaks, thereby 
protecting Americans at home and abroad.
Accomplishments in 2011
GDD Regional Centers
■ 74 epidemiologists and laboratory scientists graduated from the Field Epidemiology 
Training Programs (FETP) associated with GDD Regional Centers
■ 530 FETP graduates remained in public health positions in-country or within the region 
after graduation
■ More than 15,000 people participated in short-term public health training. Instruction 
included a combination of advanced training for core public health personnel and more 
basic training for clinicians and others working in public health
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Building Capacit
Figure 1. Building Human Resource Capacity
Over the last six years, 376 doctoral level epidemiologists have been trained in the GDD 
Regional Centers. This advances global public health towards the goal o f 1 senior 
epidemiologist per 200,000people.
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Figure 2. C um ulative Num ber o f Training Participants
Nearly 65,000people have participated in both formal and informal training.
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Strengthening Influenza Vaccination in Thailand: 
10 Years of Collaboration
Prevention of influenza remains an important global health challenge, particularly in largely populated regions 
such as Southeast Asia. Due to a large amount of global migration from Southeast Asia, influenza that originates 
in this region has a high risk of international transmission, including to the United States. CDC’s Influenza 
Division has carried out influenza program activities in Thailand since 2001. At that time, investments in 
influenza prevention by the Government of Thailand were extremely limited, and mostly focused on giving fewer 
than 100,000 doses of influenza vaccine to a select group of Mecca pilgrims.
Since 2001, however, CDC and partners have worked with the Ministry of Public Health in Thailand to establish 
the foundation for and then implement the beginnings of an influenza public health program. Efforts began with 
a series of strategic activities related to influenza, including beginning surveillance for pneumonia and influenza, 
identifying risk factors for people hospitalized with influenza, defining seasonality, and estimating the burden 
and cost of influenza disease, including publication of the incidence of influenza pneumonia in the country.
By 2007, the Ministry of Public Health in Thailand had developed a pandemic influenza preparedness plan. In 
2008, Thailand began providing influenza vaccination to adults 65 years or older and by 2011, the recommended 
target groups expanded and Thailand was giving approximately 2.8 million doses of influenza vaccine through 
the public sector.
The situation in Thailand shows how capacity building and relatively small investments provided by CDC can 
generate tremendous public health benefits. From 2001 to 2011, CDC influenza investments in Thailand totaled 
about $10 million. During that same time period, the Government of Thailand investgradually increased its 
investment, ultimately providing more than $97 million into its influenza program, benefiting more than 2.8 
million people each year, and helping to prevent the global spread of disease.
Figure 3. The Catalyst Effect: Expansion o f  Influenza Investm ents in Thailand.
CDC investments helped Thailand to document the burden of influenza and make the case for 
increased use o f flu  vaccine. Since that time, Thailand has invested $97 million into its influenza 
programs, protecting Thai citizens and others against the disease.
* CDC Activities are jointly supported by the Influenza Division and the Division of Global Disease Detection 
and Emergency Response
** Vaccine production and distribution estimated at $12/dose.
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Building Capacit
China Field Epidemiologists Grow in Numbers, Location and 
Knowledge Base
With a population of 1.3 billion, China has taken on an aggressive goal regarding 
its public health workforce. Although there are approximately 625,000 public health 
workers, fewer than 100 have graduated from the Chinese FETP. A key component of
GDD’s Regional Centers is working closely with CDC’s Division of Public Health Systems 
and Workforce Development to implement an applied epidemiology program to help 
foreign countries develop and strengthen their public health workforce. For the GDD 
Regional Center in China, developing partnerships with the Chinese government has 
been an important element of establishing, supporting and sustaining public health 
programs such as the FETP. The Chinese government, with technical assistance from 
CDC, supported an expansion plan of the FETP by providing new staff positions, office 
and training facilities. The main focus was to increase class size to at least 80 per year 
by 2015. The first success has been the increase in class size from 15 to 32 in 2011along 
with an increase in FETP sites at the provincial and city level to a total of 19 sites. At this 
pace, FETP is poised to help the Chinese meet their goal by 2015.
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Keeping Laboratories in Uganda Safe
In 2010, a congressional delegation and Pentagon officials visited laboratories at the 
Uganda Virus Research Institute. The delegation expressed concerns about what they 
saw: broken windows, simple padlocks, lack of basic laboratory equipment, insecure 
storage of dangerous pathogens, and other biosecurity hazards.
CDC’s Global Health Security Branch maintains a productive relationship with the 
Ugandan Virus Research Institute. Following the delegation’s visit, Ugandan colleagues 
were interested and willing to make the changes necessary to upgrade biosecurity and 
biosafety at their facilities. In 2011, CDC, DOD, and DOS combined their efforts and 
expertise to build a secure repository for pathogens at the Institute. This work resulted in 
installation of a high-security vault for pathogens such as Ebola fever, Marburg fever, and 
Bacillus Anthracis, and will provide a secure facility for dangerous pathogens.
Outside of Uganda, CDC, DOD and 
DOS are working together to create a 
framework for building a comprehensive 
regional biological security program in 
East Africa. This approach aims to improve 
biosecurity through multiple avenues, 
including secure physical facilities 
and by building a robust public health 
observation and communication network 
to improve public health and counter 
bioterrorism. Most importantly, this effort 
will merge the various U.S. government 
programs to ensure complete, proactive, 
and coordinated efforts towards global 
laboratory biosecurity. Ultimately, secure 
and safe laboratories internationally 
will mean increased compliance with 


















Rapid detection at the source of an event saves vital time needed to deploy countermeasures 
and implement strategies to save lives and prevent the spread of disease across borders. CDC 
experts collaborate with MOHs to keep their citizens safe and protect Americans against the 
spread of disease. In addition, GDD Regional Centers help countries to establish or significantly 
improve laboratory testing capacity to confirm emerging health threats and implement 
appropriate response interventions more quickly.
Accomplishments in 2011
GDD Regional Centers
■ Detected 7 pathogens new to their region
■ Discovered 3 organisms new to the world
■ Built host nation capacity for 17 new diagnostic tests
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Monitoring and Detecting Threats
Figure 4. C um ulative Num ber o f N ew  
P ath ogen s D etected  and Testing Capacity
By transferring technology and laboratory expertise from CDC to the field, we are able to 
track new pathogens that are new to the region and the world.
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Table 1. P ath ogen s D etected , 2011
GDD Regional Center Pathogen Name New to
Bangladesh Nipah virus Mode of Transmission
Bangladesh Avian Influenza A H9N2 New to Region
Guatemala Candidatus Bartonella desmodus * World
Guatemala Influenza A/bat/Guat/09, bat conaviruses, bat adenoviruses, bat polyomavirus,bat paramyxoviruses, bat astroviruses, bat rotaviruses, bat herpsviruses, bat parvoviruses* World
Kazakhstan Metapneumovirus Region
Kazakhstan Norovirus Region
Kenya Candidatus Rickettsia asemboensis, bat conaviruses, bat adenoviruses, bat polyomaviruses, bat paramyxoviruses, bat rhabdoviruses* World
Thailand Bartonella vinsonii Region
Thailand Aspergillus flavus Region
Thailand Streptococcus equi Region
Thailand Streptococcus difficilis Region
India Crimean-Congo hemorrhagic fever variant Region
1 Isolate characterization is expected in 2012.
* Organisms new to the world typically require additional investigation to assess human pathogenicity.
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Teaming up to address "Brain Fever" in India
While acute encephalitis, or brain infections, occur world-wide, they are especially 
prevalent in Asian countries with a high burden of the mosquito-borne disease Japanese 
encephalitis. India introduced vaccination for Japanese encephalitis in several states 
during 2006, resulting in a drop in cases; but several areas of the country continue to be 
plagued with large outbreaks of “brain fever” during the rainy season each year. These 
outbreaks affect over 5,000 people in India, most of them children. Many are permanently 
disabled and 700 people die each year.
At the request of the Government of India, the GDD Regional Center made strengthening 
encephalitis surveillance and outbreak investigation one of its priorities. CDC formed 
the Encephalitis Working Group to develop intensive sentinel surveillance in select 
hotspots to better characterize the incidence and causes of encephalitis in that area. The 
implementation of this surveillance system will build capacity to diagnose preventable 
and treatable causes of encephalitis and detect potential emerging pathogens that 
might be contributing to outbreaks. The results of this project will be critical to guiding 
effective control measures and will inform the approach to comprehensive encephalitis 
surveillance and control in other affected regions of India.
Reservoirs of Infectious Disease in Bats
In the movie Contagion, the deadly outbreak of a novel, fictitious virus, originating from 
bats, spread around the world in a matter of days. In real life, infectious diseases continue 
to emerge and re-emerge and bats are the real source for many of these. Despite the 
threat for serious consequences of outbreaks from viruses associated with bats, such as 
rabies, Nipah virus, and Marburg/Ebola hemorrhagic fever, far too little 
is known about the ecology of bat-borne viruses.
Bats are abundant in the tropics, and frequently roost in close 
proximity to people, sometimes forming large colonies of one or 
several species. Last year the GDD Regional Centers in Bangladesh,
Guatemala, and Kenya along with the National Center for Emerging 
and Zoonotic Infectious Diseases, researched the threats that bats 
present to Americans abroad and the global community.
Bangladesh
For the past decade, the GDD Regional Center in Bangladesh has 
been coordinating with the Government of Bangladesh to respond to 
Nipah virus outbreaks caused by consuming raw sap from palm trees.
Nipah virus causes inflammation of the brain and commonly leads to 
death. The sap can be contaminated with saliva, urine and feces from 
bats that carry the disease. In 2011, the Government of Bangladesh 
based their prevention strategy on CDC surveillance data and made 
recommendations via mass media to avoid consuming raw tree sap.
The GDD Regional Center in Bangladesh continues to be involved in 
assessing the impact of the government’s recommendations to keep 
citizens and visitors safe from disease.
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Monitoring and Detecting Threats
G uatem ala
In 2011, the GDD Regional Center in Guatemala worked closely with CDC’s Division 
of Vectorborne Diseases and Universidad del Valle de Guatemala in rural and urban 
regions of Guatemala to collect specimens from bats to determine the prevalence of 
pathogens, including novel types of Bartonella, known to be associated with bats. 
Bartonella is recognized as a significant cause of acute and chronic disease globally.
In 2011, a new Bartonella organism was found, highlighting the role that bats may play 
as a major reservoir for maintenance and transmission of Bartonella to other animals and 
humans. In collaboration with the Division of Viral Diseases, CDC has also detected many 
new novel viruses in bats including Influenza viruses (see Table 1). By identifying these 
novel agents of disease through laboratory testing, CDC and its partners can reduce the 
disease threat and improve clinical standards of care.
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Rapidly Testing for Rabies in Kenya
Rabies is nearly always fatal if preventive measures are not taken after exposure. 
Worldwide, more than 55,000 people die from rabies every year. The ability to diagnose 
rabies in both animals and people is the cornerstone for rabies prevention and control. In 
Kenya, veterinary and public health agencies have limited capacity for conducting rabies 
diagnoses in their laboratories and overall, a more practical and cost-effective method for 
diagnosing rabies in Kenya and other developing countries is needed.
A Direct Rapid Immunohistochemical Test for rabies diagnosis was recently developed by 
CDC’s Division of High-Consequence Pathogens. The technique offers a rapid, specific, 
sensitive and cost-effective tool for diagnosing the disease. The test is ideal for the field 
as it can be performed on a bench-top at ambient temperature, requires no specialized 
equipment, provides diagnostic results in one hour, and does not require electricity.
In August 2011, the GDD Regional Center in Kenya provided training in the use of the 
rapid test to multiple organizations including the Kenya Veterinary Association, Kenya 
Medical Research Institute, National Public Health Laboratories Services, and the Central 
Veterinary Laboratories. This training proved valuable as shortly after, the GDD Regional 
Center assisted the Kenyan laboratories in an investigation of human exposures to a rabid 
zebra at a safari lodge. The zebra was confirmed rabid at the GDD Regional Center in the 
Nairobi, Kenya laboratory using the rapid test technology. Nearly 200 tourists from 17 
countries were identified as having potential exposure to the rabid zebra, including 30 
U.S. tourists, with several requiring post-exposure prophylaxis. As a next step forward, 
the GDD Regional Center in Kenya will begin implementation of enhanced rabies 
surveillance with establishment of rabies diagnosis in veterinary and public 
health laboratories.
Millions of tourists travel to Africa and other regions for vacation and safari. Having 
readily available and easy-to-use technology in remote areas of the developing world 
will ultimately keep Americans safe as they travel. As a result of this technology transfer, 
Kenya is now better able to respond to cases of rabies and protect people, both Kenyans 
and foreign nationals, from sickness and death. In addition, this technology is being 




















The threat posed by emerging pandemics remains a challenge to global security by putting 
economic and political stability at risk. In addition, populations affected by natural disaster, 
war, famine, and civil strife are vulnerable to diseases. This is compounded when health and 
other government infrastructure has been damaged or is not functioning. CDC seeks to diffuse 
these risks by providing scientific and technical expertise to protect and improve the health of 
emergency-affected populations.
Accomplishments in 2011
GDD Regional Centers help build national and regional capacity. In 2011, outbreak responses 
Were Timely
■ 81% received a response within 24 hours of the request
Were Comprehensive
■ 84% involved laboratory support
■ 52% included health communication support
■ 29% included support to other countries
Achieved Public Health Impact
■ 70% led to identification of modifiable risk factors
■ 35% led to saving of lives, preventive action, or policy change
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Responding to International Emer
Figure 5. C um ulative Num ber o f O utbreak R esponses
Over the past six years, GDD Regional Centers have responded to 911 disease outbreaks.
2006 2007 2008 2009 2010 2011
Headquarters Responses to Emergencies
Some outbreak responses supported through the GDD program are complex or cross 
national and regional boundaries and require a CDC headquarters-based response. 
Through its surveillance function, the GDD Operations Center in Atlanta is frequently 
the first to alert CDC staff (based in Atlanta and internationally) about a disease 
outbreak. The GDD Operations Center utilizes multiple sources of information about 
disease events, including internet-based media reports which scan for key words in 
more than 40 languages. To investigate and confirm the existence of these outbreaks, 
the GDD Operations Center relies on a global network, including CDC subject matter 
experts and their international networks, WHO Headquarters and regional offices, 
and other international partners. The GDD Operations Center is also a member of 
the Biosurveillance Indications and Warning Analytic Community, a U.S. government 
interagency collaboration that allows 12 agencies to exchange unclassified information 
through a secure Web-based portal. The GDD Operations Center is also CDC’s liaison 
with the WHO’s Global Outbreak Alert and Response Network, receiving and responding 
to requests for international assistance to control disease outbreaks. In 2011, the GDD 
Operations Center supported 20 outbreak investigations in 17 countries (see Table 2).
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Table 2. List o f O utbreaks Supported  by GDD O perations Center, 2011








Cholera Haiti ✓ ✓ ✓ Continued emergency deployments and material support for controlling the cholera epidemic
Typhoid Uganda ✓ ✓ ✓
Deployed a team to provide epidemiologic and laboratory technical assis­
tance, provided equipment and supplies for training on typhoid case manage­
ment, surveillance, and prevention, and provided startup supplies for blood 




and Uganda ✓ ✓ ✓
Deployed a team to South Sudan to assist in a field investigation, verified 
the clinical illness as Nodding Syndrome, and conducted a case-control 
study in order to substantiate significant risk factors for Nodding Syndrome 
as identified in Uganda, DVD employed a panel of pan viral family or group 
PCR assays and a deep sequencing approach to further understanding of 
Nodding Syndrome
Polio Republic of the Congo ✓ ✓
Supported deployments for Supplemental Immunization Activities (SIAs), 
National Immunization Days (NlDs), Sub-National Immunization Days (SNIDs) 
and other immunization campaigns
Cholera DominicanRepublic ✓ ✓ ✓
Validated laboratory testing for proper diagnosis, assisted with the investiga­
tion into high hospital cholera mortality rates, and recommended improve­
ments in the quality of clinical care
Yellow Fever Uganda ✓ ✓ ✓
Deployed a team to assist in the epidemiologic and laboratory components of 
the outbreak investigation, including enhancing surveillance, characterization 
of the outbreak, and identifying risk factors unique to this particular outbreak 
of yellow fever
Unexplained 
Liver Disease Ethiopia ✓ ✓
Deployed staff and supplies to continue investigations into the etiology 
of the disease
Rabies (Bat) Peru ✓ ✓ ✓
Deployed staff to assist with specimen collection and shipment, and other 





Thailand ✓ ✓ Led an investigation into possible etiologies, including testing by of available tissue specimens and toxic agents
Ebola Uganda ✓ ✓ ✓
Deployed staff to provide epidemiologic and surveillance assistance, labora­
tory support, clinical case management and infection control, social education 
and mobilization, and provided supplies of Personal Protective Equipment kits
Anthrax Anthrax ✓ ✓
Conducted a community-based survey focusing upon risk factors for 
exposure, with findings and potential interventions shared with the 
Ministry of Health
Nosocomial
Klebsiella Panama ✓ ✓
Deployed a team to assist in the investigation, make recommendations on 






Deployed a team to investigate the outbreak, review laboratory and surveil­
lance data, and provided recommendations for implementing improved 
surveillance and precautionary measures to reduce the spread of HFMD
Typhoid Zimbabwec ✓ ✓ ✓
Deployed a team to investigate the source of the outbreak, provided technical 
consultation for confirmatory and additional laboratory testing including 
rapid tests, molecular subtyping, and antimicrobial susceptibility, tested wells 
to insure access to clean water
Acute Febrile 




Yemen ✓ Provided laboratory testing materials to more rapidly establish the etiology of the outbreak
Dengue MarshallIslands ✓ ✓ ✓
Deployed a team to provide on-site technical assistance
including epidemiologic investigation, clinical management, rapid diagnostic
tests and vector control, supported shipment of samples to CDC labs
Guillain-Barre
Syndrome Mexico ✓ ✓ ✓
Deployed CDC staff to determine the etiologic source of the outbreak and 
support laboratory testing and needs
Dengue Micronesia ✓ ✓ ✓ Supported shipment of samples to CDC labs, deployed a CDC investigation team, sent rapid diagnostic tests, and assisted in vector control efforts
Dengue Pakistan ✓ ✓ ✓ Shipped laboratory specimens to CDC labs for testing
‘Equipment and Supplies includes printing, contractual services, transportation of items, and communications
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Responding to International Emer
Typhoid Fever: Multi-Region Responses in Africa
Typhoid fever is a forgotten scourge for most of the developed world. This disabling disease 
of poverty occurs most often in children from five to 19 years old and is responsible for 
an estimated 16-33 million cases and 210,000-600,000 deaths every year. While developing 
countries with poor sanitation and sewage treatment are especially vulnerable to typhoid 
outbreaks, typhoid fever is also a concern for developed countries. In the United States, over 
75% of typhoid fever cases are acquired while traveling internationally.
In September 2011, the MOH in Uganda contacted CDC to report increasing cases of typhoid 
fever associated with intestinal perforation and formally requested assistance. This outbreak 
has been an ongoing struggle and was investigated by CDC in 2009, but in 2011 cases 
began to increase again and to spread to new areas in the country. CDC pooled resources 
from Atlanta, including the GDD Operations Center and enteric disease epidemiology 
and laboratory experts from the Division of Foodborne, Waterborne, and Environmental 
Diseases, National Center for Emerging Zoonotic and Infectious Diseases, along with staff 
from CDC-Uganda and CDC-Kenya to send an investigation team to Uganda. This team 
provided epidemiologic and laboratory expertise and training assistance to over 100 health 
facilities and indirectly supported the Ugandan MOH to develop response measures, improve 
laboratory diagnosis, increase water quality testing, implement health education messages, 
and conduct trainings on case management, surveillance, and prevention to 169 health 
workers from the health facilities.
In October 2011, the Ministry of Health and Child Welfare in Harare, Zimbabwe began 
reporting cases of typhoid fever to CDC-Zimbabwe. The response again combined resources 
from the Kenya GDD Regional Center Laboratory Program, the South African FETP, part of 
the GDD Regional Center in South Africa, and experts from CDC headquarters to respond 
to the outbreak with support from the GDD Operations Center contingency fund. CDC 
assisted with the epidemiologic and laboratory investigation, enhanced surveillance and 
water testing, and provision of laboratory supplies. Meeting with MOH officials, the outbreak 
response team also recommended community education interventions and health education 
messages. The international team significantly contributed to addressing this outbreak and 
the number of typhoid cases had decreased considerably by the time the team departed.
Responding to the Crisis in the Horn of Africa
R esponding to  th e  D eadliest Famine in D ecades
A drought in 2011 in Somalia, northern Kenya, and eastern and southern Ethiopia resulted in 
widespread crop failure and livestock mortality. Coupled with political instability and conflict 
in Somalia, this led to the most severe food security emergency in decades. Large portions 
of the Somali population, a high percentage of them women and children, fled to Kenya and 
Ethiopia. These populations were vulnerable to malnutrition, life-threatening disease, and 
violence as they walked hundreds of miles in hopes of reaching refugee camps such as the 
Dadaab camp complex in northern Kenya. Many died during the exodus, and those who
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arrived were often severely malnourished, sick, and traumatized. Throughout 2011,
CDC’s refugee health experts provided critical support to multi-lateral partners in 
responding to this humanitarian crisis.
H elping to  D efine th e  M agnitude o f th e  Crisis
Early in the crisis, conditions were deteriorating rapidly. The worst affected areas were 
in the Al-Shabaab-controlled region of southern and central Somalia where humanitarian 
aid workers were not allowed. With limited access and information, the United Nations 
Food Security and Nutrition Analysis Unit struggled to determine whether conditions
constituted an official declaration of famine, an important step in mobilizing the 
international community and directing resources. Scientists from CDC received a request 
to help assess data quality and provide a scientific method for analyzing the available 
data in order to determine nutritional status, morbidity, and mortality. Famine is defined, 
in part, by a population-based mortality rate greater than 2 deaths per 10,000 people per 
day and global acute malnutrition exceeding 30%. Based on CDC data, conditions within 
Somalia were found to be above these emergency thresholds and on July 20th, 2011, the 
UN announced that a famine existed in two areas of southern Somalia and was expected 
to spread across the southern zone of the country. CDC’s contributions were critical 
in establishing a famine declaration, thereby focusing the international community to 


















Once an emergency situation is stabilized, CDC's focus shifts from the emergency response 
phase to reconstruction. Public health challenges hinder developing economies and threaten the 
overall stability of vulnerable countries. By assisting countries to build or rebuild public health 
systems after disasters, CDC supports not only improved health outcomes, but also political 
and economic benefits. CDC leverages expertise across the agency to strengthen public health 
systems in need of reconstruction.
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Reconstructing Public Health System
Rebuilding Haiti
On January 12, 2010, a massive, 7.0 magnitude earthquake struck Haiti, killing an 
estimated 200,000 people and destroying an already weak national infrastructure.
Roads and ports were badly damaged, homes reduced to rubble, and remaining clinics 
overwhelmed by multitudes of people with severe traumatic injuries. There was an 
immense public health need in Haiti and a fragile health system unable to respond. CDC’s 
response was immediate—soon after the earthquake struck, CDC supported the Haiti 
MOH and provided resources (including staff and funding) to strengthen and reconstruct 
Haiti’s public health system. However, due to the uncertain political situation and 
magnitude of devastation, the risk for disease outbreaks remained high. On October 21 of 
that year, reports of rapidly increasing numbers of watery diarrhea cases in the Artibonite 
Department gained worldwide attention. A CDC field team composed of epidemiologists 
and laboratory scientists from the MOH began an immediate investigation and identified 
cholera as the pathogen. Within a month, the cholera outbreak had swept across Haiti 
and beyond its borders. The CDC’s Health Systems Reconstruction Office (HSRO) 
played a substantial role in response to the public health needs for Haiti as well as 
cholera-affected nations elsewhere. From building laboratory capacity and public health 
professional capabilities, to community assessments, and establishing cholera treatment 
facilities throughout Haiti, CDC and other partners’ efforts have worked to contribute in 
these areas. A sampling of CDC’s accomplishments in reconstructing the public health 
systems in Haiti are summarized below.
Table 3. Public Health Legacy G oals for Haiti by 2015
Legacy goals are shared high-level public health goals that the U.S. government, the Haiti 
Ministry of Public Health and Population (MSPP), and other partners are working 
towards that will leave a lasting, improved public health legacy from post-earthquake 
reconstruction efforts. CDC contributes to these seven legacy goals, but cannot claim sole 
credit for, nor be held solely responsible for, their success or failure.
1. Eliminate mother to child transmission of HIV
2. Eliminate the threat of epidemic cholera
3. Eliminate Lymphatic Filariasis
4. Ensure a robust, sustainable, self-correcting public health system
5. Reduce the under-five mortality rate from vaccine preventable diseases by 35%
6. Reduce maternal mortality by 30%
7. Reduce the prevalence of tuberculosis (TB) by 25%
Strengthening and expanding national laboratory systems
Following the earthquake, laboratory scientists were left without both laboratory 
space and microscopes to perform necessary cultures, confirmatory tests, and strain 
identification. Medical professionals, without access to lab tests, could not provide 
appropriate care.
To address the diagnostic needs for TB, CDC provided funding and technical expertise to 
build a new lab space within Haiti’s National Public Health Laboratory. CDC laboratory
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subject matter experts also provided training to lab staff for bio-safety, culture, and drug 
susceptibility testing. Such action was important to address Haiti’s TB incidence rate, the 
highest in the Western Hemisphere.
To address the diagnostic needs for 
malaria, CDC procured 5,000 rapid 
diagnostic tests and, in collaboration 
with the MOH, distributed the test 
kits and provided training to partners. 
After an assessment demonstrated the 
test kit’s high performance and ease 
of use in resource-limited settings, 
the national policy was amended 
to include the three top performing 
test kits for malaria diagnostics. CDC 
subsequently procured 130,000 rapid 
diagnostic test kits which will be 
piloted in 90 facilities in 2012.
Cholera Treatment: CDC Efforts Save 7,000 Lives
One of the largest recent cholera epidemics to affect a single country began in Haiti 
in October 2010; just 10 months after the devastating earthquake had struck. Within a 
month, cholera had spread throughout Haiti and cases were being reported by its shared 
island neighbor, the Dominican Republic.
HSRO and partner program staff from across CDC responded beginning on the day 
of cholera detection. In partnership with colleagues from the Haiti MOH and the 
International Centre for Diarrheal Disease Research in Bangladesh, CDC developed 
education materials and a training course for the clinical management of cholera that 
reached over 500 clinical staff across Haiti’s ten departments through a cascading 
training approach. In addition, CDC developed a training manual (in French, Creole and 
English) on cholera education and prevention for community health workers (CHWs), 
the backbone of the medical workforce in rural Haiti. CDC and the Haiti Ministry of 
Health conducted a training course for master trainers from all 10 departments, who 
subsequently trained more than 1,000 CHWs using the CDC cholera materials. CDC 
also coordinated resources and worked with partners to establish and support cholera 
treatment facilities throughout Haiti. As of December 2011, CDC was supporting 17 
cholera treatment centers, 25 cholera treatment units, and 485 oral rehydration points. 
CDC also provided technical assistance to the MOH to establish and implement a 
cholera surveillance system to monitor the spread of disease and treatment efficacy. By 
reducing the mortality from 3-4% during the initial weeks of the outbreak to below the 
international target of 1%, these efforts are estimated to have saved more than 7,000 lives 
in the first year of the Haiti outbreak.
One year after the initial outbreak:
■ Total cholera cases: 485,092
■ Hospitalized cases: 259,549
■ Total deaths: 6,712
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Appendix
Appendix A: Table of GDD Accomplishments: 2011 and Cumulative
This table contains summary statistics for each of the GDD Regional Center activities for 2011 as well as cumulative 









Total number of outbreak responses 242 911
Number of outbreaks in which response time was within 24 hourst 195 81% 585 77%
Number of outbreaks in which epidemiological activities helped identify 











Number of outbreak responses that achieved measurable health impact 
(saving lives, prevention of disease spread, or policy change) 85 35% 345 45%
Number of outbreak responses in which GDD lab support was provided 204 84% 541 59%
Number of outbreaks in which GDD lab support provided 
pathogen confirmation 195 96% 481 89%
Number of outbreaks in which communication support was providedt 125 52% 344 45%
Number of responses that included support to other countries* 71 29% 222 38%
Number of outbreaks that involved CDC headquarters support* 21 9% 131 17%
Number of outbreaks that involved WHO or Global Outbreak Alert and 











Total number of new pathogens detected 12 66
Number of pathogens new to the region 7 58% 53 80%
Number of pathogens new to the world 4 33% 10 15%
Number of new modes of transmission 1 8% 4 6%
Number of pathogen-specific tests available in-country 17 202





Number of Field Epidemiology (and Laboratory) 
Training Program (FE(L)TP) graduates 74 376





Total population under surveillance for pneumonia 5,600,000
Total population under surveillance for other diseases and syndromes 72,455,166
Total number of other diseases and syndromes under surveillance 13
* Also contributes to  "Networking" activity area
t  Indicator was not collected for all years. The denominator for these percentages are based on the number o f outbreaks conducted during the years that indicator 






a Supporting global health is good for Americans’ 
health. It’s good for Americans’ health because 
stopping epidemics and environmental and other 
threats to health overseas and foreign countries 
before they spread to our shores is not only the 
most ethical, but also the cheapest and most 
effective way to protect Americans.
— Dr. Thomas R. Frieden, Director of the CDC. November 22nd, 2011.
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